Clinical Trials Browser

Phase 2 × INDUSTRY × abivertinib × Clear all

NCT05361915 2024-03-18

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Phase 2 Suspended

Prostatic Neoplasms

NCT03300115 2019-02-19

Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung